Kepler Capital Sticks to Their Hold Rating for Galapagos (GLPG)
Earnings Call Summary | Galapagos(GLPG.US) Q1 2024 Earnings Conference
The following is a summary of the Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript:Financial Performance:Galapagos reported a net profit in Q1 2024 driven by adjustments in fair value, foreign exc
Galapagos First Quarter 2024 Earnings: EPS: €0.36 (Vs €0.35 in 1Q 2023)
Galapagos NV Reports Strong Q1 2024 Financials
Galapagos Reports Q1 Results
Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Revenue €62.4 Million Vs €58.6 Million YoY
Results from our continuing operationsTotal operating loss from continuing operations for the three months ended 31 March 2024 was €33.1 million, compared to an operating loss of €14.2 million for the
Galapogos 1Q EPS EUR1.40 >GLPG.BT
Galapogos 1Q EPS EUR1.40 >GLPG.BT
Galapogos: Reconfirmed 2024 Cash Burn Guidance of EUR280M to EUR320M, Not Including Potential Business Development Opportunities >GLPG.BT
Galapogos: Reconfirmed 2024 Cash Burn Guidance of EUR280M to EUR320M, Not Including Potential Business Development Opportunities >GLPG.BT
Galapagos NV Shareholders Approve Key Resolutions
Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV ((Euronext &, NASDAQ:GLPG) today announces that all resolutions proposed at the company's Annual and Extraordinary Shareholders' Meetings (AGM and EGM) held on
Morgan Stanley Maintains Equal-Weight on Galapagos, Maintains $38 Price Target
Morgan Stanley analyst Judah Frommer maintains Galapagos with a Equal-Weight and maintains $38 price target.
LG LAUNCHES VULNERABLE & ENDANGERED SPECIES AWARENESS CAMPAIGN IN TIMES SQUARE
3D anamorphic animal series kicks off LG's Earth Day activations; LG commits $150,000 in partnership with the National Wildlife Federation and Discovery EducationNEW YORK, April 16, 2024 /PRNewswire/
Galapagos NV Unveils CAR-T Therapy Advances
Galapagos Showcases Innovative Approach in Hematological Cancer Care With Clinical and Translational Data Presentations at EBMT Congress 2024
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen,
Galapagos Full Year 2023 Earnings: Beats Expectations
Galapagos NV Announces Shareholders' Meetings and 2023 Report
Galapagos NV Welcomes New Board Member
Galapagos Publishes 2023 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings
Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2023 and announces its Annual and Extraordinary Shareholders' Meetings (AGM and EGM) to be held sequentially on Tuesday, 30 April 2024 at 2:00 pm (CET) and 3:00 pm (CET), respectively, at the registered office of the Company.
Galapagos Continues to Be 'Value Trap' With Unclear Growth Path, BofA Says
Galapagos (GLPG) remains "a value trap and relative underperformer" with no near- or medium-term fix, BofA Securities said in a note Thursday. Analysts said Galapagos' enterprise value has stayed low
Galapagos Cut to Underperform From Neutral by B of A Securities
Galapagos Cut to Underperform From Neutral by B of A Securities
No Data